The Technology

Weight-Loss Drug Users Report Mysterious 'Flatness' and Apathy

via Vox·Feb 16

As GLP-1 weight-loss drug usage has more than doubled since 2024, a concerning psychological side effect is emerging: extreme apathy. Clinical psychologist Dr. Sera Lavelle reports patients experiencing a 'missing spark,' losing interest in previously loved activities without clinical depression. The drugs may dampen dopamine and motivation-seeking behavior beyond just food cravings, affecting gambling, shopping, and even positive life experiences. While GLP-1s offer hope for those struggling with obesity and binge eating, experts warn about the nuanced mental health impacts that extend far beyond appetite suppression.

Read Full Story at Vox

Keep thy heart with all diligence; for out of it are the issues of life.

Proverbs 4:23

God's instruction to guard our hearts reminds us that pharmaceutical solutions, while potentially helpful, can never substitute for the fullness of life found in purposeful engagement with God's design for human flourishing.

HealthScience

Related Stories

Omaha Police Fatally Shoot Woman Who Slashes Child at Walmart

Washington Times·8h ago

Former UCLA Gynecologist Pleads Guilty to Sex Abuse After Conviction Overturned

Washington Times·8h ago

Wisconsin Governor Signs PFAS Bills, Releasing $133M to Fight Forever Chemicals

Wisconsin Public Radio·yesterday

Measles Takes a Plane to Idaho, State With Worst Vaccination Rate in US

Ars Technica·yesterday
DiscussSoon
← Front Page